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Design of a lipid nanovesicle system encasing bacteriophages for 
inhalational therapy: A proof of concept. 
Abstract 
Experimental procedures 
PREPARATION OF MULTIPLE BACTERIOPHAGE T4-ENCASING LIPID NANOEMULSIONS. 
Production of multiple emulsions encompassing lipid nanovesicles with encased T4-
bacteriophages was carried out using an Ultra Turrax (model T25D from IKA) under 
heating (ca 40ºC). T4-bacteriophages were suspended in the (inner) aqueous phase 
(Win) and then dispersed in the melted oil phase, via high-speed homogenization (10 
min at 10000 rpm). The resulting W/O emulsion was further dispersed in the outer 
aqueous phase, via another homogenization cycle. The inner aqueous phase 
encompassed HCl 10 mM (from Vaz Pereira), Tween 80 (from Sigma-Aldrich) and 
impure lyophilized T4-bacteriophages (5 mg); the intermediate oily phase 
encompassed glycerol (from Merck, Darmstadt, Germany), Softisan™ 100 (from 
Sasol Olefins & Surfactants GmbH, Hamburg, Germany) and soybean 
phosphatidylcholine (from Acofarma, Spain); finally, the outer aqueous phase 
encompassed Lutrol™ F68 (poloxamer 188 from BASF, Germany) and ultrapure 
water.  
Experimental results and discussion 
Replacement of the poloxamer by Lutrol F-127 led to a substantial decrease (from 
more negative towards less negative values) in the negativity of the Zeta Potential of 
the lipid nanovesicles. 
Increasing Tween 80 concentration, up to 40% of the departing concentration, led to 
more negative Zeta Potential values, but the lipid nanovesicles seemed to be 
unstable over storage time, with notorious disaggregation (see Figure 2). 
The effect of simultaneously increasing the amounts of Tween 80 and lecithin were 
implicit in the high increase of Zeta Potential (from more negative towards less 
negative values), presumably due to accumulation of adsorbed ions at the particle 
surfaces. A lower concentration of Tween 80 proved to be suitable in producing lipid 
nanovesicles with stabler Zeta Potential and higher hydrodynamic sizes, throughout 
storage time. 
In this research effort, development and optimization of lipid nanovesicles encasing 
bacteriophage-T4 was pursued. A lipid with a mild melting temperature, 
encompassing medium-to-long chain fatty acid moieties was found most 
appropriate for the discontinuous oily phase. A homogenization timeframe of 10 
min, the use of a low concentration of Tween 80, and low bacteriophage 
concentrations were found to be critical processing variables for producing stable 
nanovesicle dispersions with diameters ranging from 115-145 nm and Zeta Potential 
values of ca. -16 mV. Inclusion of these multiple nanoemulsions in isotonic 
formulations for inhalational therapy of pharyngo-tonsillitis would possess inherent 
advantages, when compared with the current chemical antimicrobial approach, if 
bacteriophage-T4 were to be replaced by a lytic phage specific for Streptococcus 
pyogenes, in that bacteriophages are naturally harmless entities with bacteriostatic 
activity, without any toxicological risk for humans. 
Conclusions 
Inflammatory diseases that occur in the pharynx and involving both the adenoids and tonsils are 
important not only for being very frequent, but also because they often require minor surgery for 
their resolution. These structures have immunological functions leading to production of 
antibodies, and work in the local immunity of the pharynx and protection of the entire body. The 
most common etiologic agent of sore throats is Streptococcus pyogenes, an important pathogen 
of the beta-hemolytic group A which causes streptococcal pharyngitis. The emergence of 
antibiotic-resistant bacterial strains and the poor penetration of chemical antibiotics in bacterial 
biofilms raise the need for safe and effective options of antimicrobial treatment. The application 
of bacteriophages (or cocktails therefrom) has been proposed as an alternative (or complement) 
to conventional chemical antibiotics, allowing the release of natural predators of bacteria directly 
on these biofilms. The major advantage of bacteriophage-based antibiotherapy relative to its 
conventional chemical counterpart is that bacteriophages replicate at the site of infection, being 
available in abundance where they are needed the most. When compared with chemical 
antibiotics, bacteriophages have other important advantages: (i) strong tissue permeability, (ii) 
bacteriophage concentration remains high at the focus of infection, continuously increasing with 
bacterial (host) presence, (iii) elimination of the focus of infection occurs only after eradication of 
the host bacterium, (iv) bacteriophages are fully compatible with antibiotics and may act 
synergistically, (v) they are specific against the target bacteria, (vi) have a superior ability to 
penetrate bacterial biofilms, inducing production of enzymes that hydrolyze the biofilm polymeric 
matrix, (vii) although bacteria can develop resistance to bacteriophages, isolation of new lytic 
bacteriophages is much simpler and cheaper than developing a new chemical antibiotic. In this 
research effort, development of a biotechnological process for the inhalational administration of 
a bacteriophage cocktail (endotoxin free) was pursued, using strategies of nanoencapsulation 
within lipid nanovesicles (as forms of protection for the bacteriophage against the immune 
system) to treat infectious pathologies such as pharyngo-tonsillitis caused by Streptococcus 
pyogenes. This method of targeting may have a high potential for the treatment of bacterial 
infections of the respiratory tract, since inhalation therapy is considered to be favorable to 
certain respiratory infections because the aerosol is delivered directly at the site of infection, 
accelerating the action of bacterial predators. Additionally, a smaller amount of bioactive 
substance is needed, thus preventing or reducing possible side effects. As a proof of concept 
for the nanoencapsulation strategy, and since there is not yet available a strictly lytic 
bacteriophage cocktail for Streptococcus pyogenes, a well-defined and characterized 
bacteriophage was utilized, viz. bacteriophage T4. Water-in-oil-in-water (W/O/W) multiple 
emulsions are nanosystems in which dispersions of small water droplets within larger oil 
droplets are themselves dispersed in a continuous aqueous phase. Due to their 
compartimentalized internal structure, multiple emulsions present important advantages over 
simple O/W emulsions for encapsulation of biomolecules, such as the ability to carry both polar 
and non-polar molecules, and a better control over releasing of therapeutic molecules. T4 
bacteriophage was entrapped within W/O/W multiple nanoemulsions, aiming at mimicking the 
multifunctional design of biology, optimized with several lipid matrices, poloxamers and 
stabilizing layer compositions. Physicochemical characterization of the optimized 
bacteriophage-encasing nanovesicle formulations encompassed determination of particle size, 
size distribution and particle charge, via Zeta potential analysis, surface morphology via CRYO-
SEM, and thermal analysis via DSC, whereas antimicrobial activity of the nanoemulsions 
produced were evaluated via the “spot-test” using appropriate bacterial cultures. 
OPTIMIZATION OF THE NANOFORMULATION 
 
 
Several variables were studied, viz. lipid nature, poloxamer nature, soy lecithin 
concentration and  tween 80 concentration. 
OPTIMIZATION OF THE FORMULATION PARAMETERS. 
Optimization of the multiple lipid nanoemulsion proceeded via preparation of different 
emulsions with different Tween 80 concentrations (50 to 75 mg) and different 
stabilizing layer compositions (see Table 1). 
 
DETERMINATION OF HYDRODYNAMIC SIZE (HS) AND ZETA POTENTIAL (ZP). 
Determination of the HS of the lipid nanovesicles produced, of the polydispersion 
index and of their ZP were carried out in a Zetasizer (model Nanoseries Nano-ZS) 
from Malvern Instruments. 
 
THERMAL ANALYSIS BY DIFFERENTIAL SCANNING CALORIMETRY (DSC). 
Calorimetric analyses of the nanoemulsions produced were performed in a 
differential scanning calorimeter (Shimadzu, Kyoto, Japan), which comprised a 
detector (DSC-50) and a thermal analyzer (TA-501). The samples were heated from 
room temperature to 100 ºC at a constant linear rate of 5 ºC/min, during which the 
amount of heat absorbed by the samples was recorded. 
 
EVALUATION OF ANTIMICROBIAL ACTIVITY BY THE “SPOT” METHOD. 
Optimized nanoemulsions were assessed for antimicrobial (lytic) activity, following a 
simple laboratory procedure. Whole nanoemulsions were submitted to the “spot” test 
as follows; 1. 100 µL of bacterial suspension (Escherichia coli) grown overnight at 37 
°C were added to 3 mL of top-agar; 2. Following a gentle homogenization, the top 
agar added with bacterial suspension was poured into a 90 mm Petri dish previously 
prepared with 10 mL bottom-agar and allowed to dry; 3. A 5-µL drop of the whole 
lipid nanoemulsion was then applied and allowed to dry; 4. Incubation of the Petri 
dish was then allowed at 37 °C, overnight. 
Figure 1. Physical appearance of the lipid nanovesicles (Water-in-Oil-in-Water multiple 
nanoemulsion), as observed under an optical microscope at maximum resolution (Oil 
immersion, x1000). 
Figure 6. Differencial scanning calorimetry thermograms of multiple nanoemulsions 
encasing bacteriophage-T4. 
Table 1. Optimization of processing conditions leading to an optimal 
nanoformulation encasing T4-bacteriophage. 
HYDRODYNAMIC SIZE AND ZETA POTENTIAL DETERMINATIONS 
 
 
Both the Hydrodynamic size and Zeta Potential of the several nanoemulsions 
produced were evaluated and followed throughout a prolonged storage at room 
temperature. The results obtained are displayed in Figures 2 and 3. 
Figure 2. Changes in particle Hydrodynamic Size throughout storage time. 
Figure 3. Changes in Zeta Potential values throughout storage time. 
ANTIMICROBIAL ACTIVITY DETERMINATIONS 
 
 
The preliminary results obtained for the antimicrobial (lytic) properties of the 
optimized nanoemulsion encasing bacteriophage-T4 are displayed in Figure 4 (see 
inserted arrow), clearly showing the inhibition halo produced by the whole 
nanoemulsion. 
Figure 4. Petri dish after performance of the “spot” test to the nanoemulsion encasing 
bacteriophage T4. 
CRYO SCANNING ELECTRON MICROSCOPY ANALYSES 
 
 
Lipid nanoemulsions were analyzed for microstructural and morphological 
characteristics via Cryo-SEM. Briefly, nanoemulsion samples were prepared for 
analysis as follows: (i) samples were mounted in an appropriate (aluminum) support 
inserted into a gold-coated plate; (ii) the gold-coated plate was then duly fixed in a 
transfer stick; (iii) the support containing the sample was immersed in liquid nitrogen 
(slush nitrogen); (iv) the sample was then transferred under vacuum into the SEM 
preparation chamber (also under vacuum and maintained cold via addition of liquid 
nitrogen); (v) inside the chamber, the deep-frozen sample was fractured, undergone 
sublimation (during 90 s to 300 s) by gently increasing the temperature from -140 °C 
to ca. -90 °C, and was coated with Au/Pd (during 20s); (vi) finally, the sample was 
transferred into the SEM chamber for microscopy analysis.  
Since we aimed at entrapping a bioactive lytic phage within the lipid nanovesicles, a 
lipid was chosen so as to melt down at a lower temperature, viz. Softisan 100™.  
Figure 5. Cryo-scanning electron microphotographs of bacteriophage T4-encasing 
nanoemulsions. 
MICROCALORIMETRIC ANALYSIS OF THE NANOFORMULATIONS 
 
 
Calorimetric analysis was performed in a differential scanning calorimeter 
(Shimadzu, Kyoto, Japan). For every calorimetric assay, ca. 10 mg of emulsion were 
weighed (using a microsyringe) directly into the interior of high-pressure aluminum 
pans (Shimadzu, P/N 557 201-53090, 64U3670609), and duly sealed by pressure. A 
reference aluminum pan was also prepared by simply sealing air inside an empty 
case. The samples were then heated from room temperature to 100 °C at a constant 
linear scanning rate of 5 °C/min, during which the amount of heat absorbed by the 
sample was recorded. 
 
The effect of changing the poloxamer was not very notorious in the amount of heat 
absorbed (melting enthalpy) by the lipid nanoformulation encasing bacteriophage T4, 
since nanovesicles produced with Lutrol F-68 and Lutrol F-127 exhibited nearly the 
same melting enthalpy. However, the temperature peak of heat absorption was 
significantly displaced from 35.5 °C (in the case of nanovesicles produced with Lutrol 
F-68) to 53.6 °C (in the case of nanovesicles produced with Lutrol F-127) (see Figure 
6). 
 
Thermodynamic stability of lipid nanovesicles depends upon their existing lipid 
modification. Polymorphic transitions after crystallization of triacylglycerol 
nanovesicles are slower for longer-chain triacylglycerols, as in our case, than for 
shorter-chain triacylglycerols, whereas these transitions are faster for small size of 
crystallites. The type of surfactant utilized in lipid nanovesicle formulation and their 
storage time affects the crystallinity of lipid nanovesicles and, consequently, 
degradation velocity. 
 
Bacteriophage-T4 lyophilizate alone in ultrapure water showed a melting enthalpy of 
164.34 J/gsuspension, at a temperature peak of 87.8 °C, a value clearly higher than that of 
the nanoemulsion encasing bacteriophage-T4 after 10 min of homogenization, which 
probably accounts for the stabilizing effect of the nanoencapsulation procedure. 
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